Scottish Medicines Consortium accepts pSivida’s ILUVIEN to treat DME
ILUVIEN, which provides a therapeutic benefit for up to 36 months, will now be be available in the NHS Scotland for the treatment of vision impairment related with
ILUVIEN, which provides a therapeutic benefit for up to 36 months, will now be be available in the NHS Scotland for the treatment of vision impairment related with
In 2012, Mogamulizumab was launched in Japan under the brand name POTELIGIO Injection 20 mg for the treatment of patients with relapsed or refractory CCR4-positive ATL. In July
During the trial, EYLEA 2mg dosed monthly and every two months (after 5 initial monthly injections) demonstrated an improvement from baseline in best corrected visual acuity (BCVA) at
The protocol was filed under the company’s existing IND for ORMD-0801 to include both type 1 and type 2 diabetes indications. The double-blind, randomized, placebo controlled, seven-day trial
The company has partnered with Ludwig Cancer Research over the last year to identify small molecule inhibitors of the enzyme that display nanomolar potency, good selectivity, favorable pharmacokinetics
HoFH impairs the function of the receptor responsible for removing LDL-C (bad cholesterol) from the body and the loss of LDL receptor function results in extreme elevation of
The company said that it will produce the new Diego Pellicer Gold extracts in both capsules and cannabis oil (for vapor use) in Pheroid and non-Pheroid versions to
Based on these results, the company intends to apply for the addition of the subcutaneous route, alongside the intramuscular route, to the label of triptorelin pamoate 11.25mg. The
In the trial, RAS specific immune responses were induced in all six patients and no substantial TG01 related toxicity was observed in the patients. Oslo University Hospital professor
MG01CI (Metadoxine extended-release) is intended for the treatment of cognitive dysfunctions, such as attention deficit hyperactivity disorder (ADHD) and Fragile X Syndrome. Principal investigator of the trial will